We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLRZ
11701
Polyrizon Ltd
PLRZ
$22.9M
$83.2K ﹤0.01%
+26
New +$49.5K
NEXN
11702
PUT
Nexxen International
NEXN
$583M
$83.2K ﹤0.01%
+8,300
New +$73.5K
INMB icon
11703
PUT
INmune Bio
INMB
$60.2M
$83.1K ﹤0.01%
17,800
-28,600
-62% -$149K
VNQI icon
11704
PUT
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
$83.1K ﹤0.01%
2,100
-500
-19% -$21.6K
FOR icon
11705
CALL
Forestar Group
FOR
$1.5B
$82.9K ﹤0.01%
3,200
-11,800
-79% -$353K
ESPR
11706
CALL
DELISTED
Esperion Therapeutics
ESPR
$82.9K ﹤0.01%
37,700
-35,000
-48% -$81.7K
III icon
11707
CALL
Information Services Group
III
$250M
$82.8K ﹤0.01%
24,800
-15,500
-38% -$51.8K
BNR
11708
Burning Rock Biotech
BNR
$93.1M
$82.8K ﹤0.01%
+12,267
New +$56.5K
AVNS
11709
PUT
DELISTED
Avanos Medical
AVNS
$82.8K ﹤0.01%
5,200
+200
+4% +$3.96K
ELMD icon
11710
PUT
Electromed
ELMD
$341M
$82.7K ﹤0.01%
2,800
-900
-24% -$23.5K
HTHT icon
11711
CALL
Huazhu Hotels Group
HTHT
$12.9B
$82.6K ﹤0.01%
2,500
-4,800
-66% -$174K
IGIB icon
11712
PUT
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$82.4K ﹤0.01%
1,600
+1,200
+300% +$62.8K
WKHS icon
11713
PUT
Workhorse Group
WKHS
$33.3M
$82.4K ﹤0.01%
787
+135
+21% +$18.4K
XENE icon
11714
PUT
Xenon Pharmaceuticals
XENE
$6.03B
$82.3K ﹤0.01%
2,100
-1,500
-42% -$62K
MCR
11715
DELISTED
MFS Charter Income Trust
MCR
$82.1K ﹤0.01%
+12,872
New +$81.6K
BANF icon
11716
PUT
BancFirst
BANF
$3.89B
$82K ﹤0.01%
700
+500
+250% +$58.6K
TYO icon
11717
CALL
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.7M
$81.9K ﹤0.01%
+5,500
New +$77K
PLYM
11718
PUT
DELISTED
Plymouth Industrial REIT
PLYM
$81.9K ﹤0.01%
4,600
+2,800
+156% +$55.3K
TCPC icon
11719
CALL
BlackRock TCP Capital
TCPC
$342M
$81.9K ﹤0.01%
9,400
+5,300
+129% +$45.8K
QQQY icon
11720
Tidal Trust II Defiance Nasdaq 100 Weekly Distribution ETF
QQQY
$189M
$81.8K ﹤0.01%
+2,652
New +$88.7K
VERV
11721
CALL
DELISTED
Verve Therapeutics
VERV
$81.8K ﹤0.01%
14,500
+7,000
+93% +$39.5K
REE
11722
DELISTED
REE Automotive
REE
$81.7K ﹤0.01%
+9,258
New +$74K
FDD icon
11723
First Trust STOXX European Select Dividend Income Fund
FDD
$916M
$81.6K ﹤0.01%
+7,248
New +$85.1K
NREF
11724
PUT
NexPoint Real Estate Finance
NREF
$319M
$81.6K ﹤0.01%
5,200
+4,000
+333% +$64K
VYMI icon
11725
PUT
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
$81.5K ﹤0.01%
1,200
-2,300
-66% -$163K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.